CAXFILA 40MG OS ORAL SUSPENSION 240 ML

Yes, it is a common side effect which is caused due to an increase in appetite. It leads to an increase in fat and body mass. If there is excessive weight gain patients are advised to consult the doctor.

No, it is unsafe to use this medication in pregnancy because it causes harmful effects in the developing baby. Patients are asked to avoid this medication if they are planning for pregnancy or during pregnancy.

No, it doesn't stop periods and it can cause excessive bleeding. consult the doctor if there is any excessive bleeding.

The common side effects of CAXFILA 40MG OS ORAL SUSPENSION 240 ML are weight gain, increase in appetite, high blood pressure, constipation, rounded face, mood changes, hair loss, tiredness and weakness, nausea, vomiting, swelling of the vein.

CAXFILA 40MG OS ORAL SUSPENSION 240 ML should be taken as prescribed by the doctor and it can be taken with or without food, preferably at the same time daily. It is important to take this medicine even when the patient is feeling well and don't stop this medication without the proper advice of the doctor as it will worsen the condition.

Before starting CAXFILA 40MG OS ORAL SUSPENSION 240 ML, inform your doctor about any history of kidney or liver problems, or allergic reactions. While taking it, kidneys, liver, blood pressure, and blood glucose levels should be monitored. Avoid this medication if you are pregnant or planning pregnancy due to harmful effects on the baby. Do not stop this medicine without your doctor's advice.

Inform your doctor immediately if you notice any signs of swelling and pain in the limbs, shortness of breath, chest pain, severe headache, or changes in vision.

The main ingredient in CAXFILA 40MG OS ORAL SUSPENSION 240 ML is MEGESTROL.

Yes, CAXFILA 40MG OS ORAL SUSPENSION 240 ML is often used in the treatment of cancer patients, particularly to help improve appetite and weight gain, which can be beneficial during cancer therapy. It is also used in hormonal therapy for certain types of cancer.

CAXFILA 40MG OS ORAL SUSPENSION 240 ML (Megestrol) is primarily used in cancer patients to stimulate appetite and promote weight gain, which can help improve their overall health and quality of life, especially when dealing with cachexia (wasting syndrome) associated with cancer.

Caxfila OS is a branded oral medicine whose exact active ingredient and approved uses depend on the specific product marketed in your region. It may be prescribed for conditions such as infections, respiratory problems, gastrointestinal issues, or other indications, depending on its composition. To know the precise use in your case, check the package insert and follow your doctor’s prescription, as only they can confirm why Caxfila OS has been recommended for you.

Take Caxfila OS exactly as prescribed by your doctor and as described in the patient information leaflet. It is usually taken by mouth using the measuring cup, spoon, or oral syringe provided with the pack to ensure accurate measurement. Swallow the dose directly; do not mix it with other liquids or foods unless your doctor or pharmacist specifically advises this. Do not change the dose or frequency on your own, and do not use household teaspoons for measurement because they are inaccurate.

If you have a history of liver disease, abnormal liver function tests, hepatitis, or cirrhosis, you must inform your doctor before starting Caxfila OS. Some oral medicines require dose adjustment, closer monitoring, or may even be avoided in moderate to severe liver impairment. Your doctor will decide whether Caxfila OS is appropriate for you, may order baseline and follow‑up liver function tests, and will advise you on warning signs such as yellowing of the skin or eyes, dark urine, severe fatigue, or persistent nausea that should prompt immediate medical review.

Patients with reduced kidney function, chronic kidney disease, or those on dialysis should use Caxfila OS only under strict medical supervision. Many medicines are eliminated through the kidneys, and impaired kidney function can increase the risk of side effects or drug accumulation. Your doctor may adjust the dose, extend the dosing interval, or choose an alternative medicine depending on your kidney function tests and the specific formulation of Caxfila OS. Never self‑medicate or alter your treatment without consulting your nephrologist or primary physician.

Use of Caxfila OS in pregnancy should be based on a careful risk–benefit assessment by your doctor. Safety in pregnancy depends on the active ingredient and the stage of pregnancy. Some medicines are considered relatively safe, while others may pose risks to the developing baby, especially in the first trimester. If you are pregnant, think you might be pregnant, or are planning to conceive, inform your doctor before starting or continuing Caxfila OS. Do not start or stop the medicine on your own during pregnancy.

Whether Caxfila OS can be used during breastfeeding depends on its active ingredient, how much of the drug passes into breast milk, and the potential effects on the nursing infant. Some medicines are compatible with breastfeeding, while others may require caution, timing of doses, or temporary interruption of breastfeeding. If you are breastfeeding, always inform your doctor before taking Caxfila OS. Your doctor will weigh the benefits for you against any possible risks to your baby and may suggest monitoring the infant for unusual sleepiness, feeding difficulties, or digestive upset.

Some oral medicines can cause side effects such as dizziness, drowsiness, blurred vision, or reduced alertness, which may impair your ability to drive or operate machinery safely. Because the exact formulation of Caxfila OS can vary, you should first see how the medicine affects you. If you feel dizzy, unusually tired, or less alert after taking Caxfila OS, avoid driving, using heavy machinery, or performing tasks that require full concentration. When in doubt, ask your doctor or pharmacist for specific advice based on the product you are using.

It is generally advisable to limit or avoid alcohol while taking prescription medicines, including Caxfila OS. Alcohol can increase the risk of side effects such as drowsiness, dizziness, stomach irritation, or liver stress, and may interfere with the effectiveness or metabolism of many drugs. Because the interaction profile depends on the active ingredient in your specific Caxfila OS product, ask your doctor or pharmacist whether alcohol is safe for you and, if allowed, in what amount. Never binge drink while on medication.

If you have ever experienced an allergic reaction to any medicine, including rashes, itching, swelling, breathing difficulty, or severe dizziness, inform your doctor before taking Caxfila OS. Provide details about the drug name, reaction type, and how it was treated. Your doctor will review the ingredients of Caxfila OS, including inactive components such as preservatives, flavoring agents, or colorants, to assess the risk of cross‑reactivity. If you develop any signs of allergy after taking Caxfila OS, stop the medicine immediately and seek urgent medical attention.

Common side effects of oral medicines like Caxfila OS may include mild gastrointestinal symptoms such as nausea, vomiting, abdominal discomfort, or diarrhea, as well as headache, dizziness, or a mild skin rash. These are often temporary and may improve as your body adjusts to the medicine. However, you should seek immediate medical attention if you experience severe or persistent vomiting or diarrhea, high fever, yellowing of the skin or eyes, dark urine, severe abdominal pain, difficulty breathing, swelling of the face or throat, or a widespread rash, as these may indicate a serious reaction or organ involvement.